Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2011-03-29
2011-03-29
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
Reexamination Certificate
active
07914979
ABSTRACT:
Envelope viruses (e.g. Newcastle disease virus (NDV)) are formulated for storage at moderately cold temperatures (e.g. −20° C.). The formulation is an aqueous solution containing the enveloped virus at a concentration of from 106PFU/mL to 1012PFU/mL; and a non-reducing saccharide (e.g. sucrose). When the non-reducing saccharide is a disaccharide it is present in the solution at a concentration of from 5% (w/v) to 50% (w/v), and when it is a monosaccharide it is present in the solution at a concentration of from 2.5% (w/v) to 25% (w/v). The solution has an osmotic pressure of about 250 mOs or higher, and has a pH of from 5 to 10.
REFERENCES:
patent: 4338335 (1982-07-01), McAleer et al.
patent: 5602023 (1997-02-01), Csatary
patent: 5792643 (1998-08-01), Herrmann et al.
patent: 6165500 (2000-12-01), Cevc
patent: 6231860 (2001-05-01), Fanget et al.
patent: 6258362 (2001-07-01), Loudon et al.
patent: 6290967 (2001-09-01), Volkin et al.
patent: 2002/0156037 (2002-10-01), Volkin et al.
patent: 2003/0044384 (2003-03-01), Roberts et al.
patent: 2003/0103933 (2003-06-01), Brody et al.
patent: 2008/0206281 (2008-08-01), Look et al.
patent: 299213 (1992-04-01), None
patent: 0028563 (1981-05-01), None
patent: 1274820 (1972-05-01), None
patent: 97/23238 (1997-07-01), None
patent: 00/62735 (2000-10-01), None
patent: 03/059292 (2003-07-01), None
Grande, et al., “Optimal conditions for the growth, purification and storage of the avian reovirus S1133”, Journal of Virological Methods, vol. 102, pp. 53-54, 2000.
Yannarell, et al., “Stabilizing cold-adapted influenza virus vaccine under various storage conditions”, Journal of Virological methods, vol. 102, pp. 15-25, 2002.
Gould, “Methods for Long-Term Virus Preservation”, Molecular Biotechnology, vol. 13, pp. 57-66, 1999.
Barrett, et al., “Growth, Purification and Titration of Influenza Viruses, in Virology: A practical approach”, Ed. B.W.J. Mahy; Raven Press Books, Chapter 6, pp. 119-145-146, 1985.
Blake, et al., :Virus Culture, Virology LabFax, Ed. D.R. Harper, BIOS Scientific Publishers Limited, Chapter 5, pp. 81-119, especially pp. 106-107, 1993.
Gelb, “Varicella-Zoster Virus”, in Virology, Ed. B.N. Fields; Raven Press, Chapter 28, pp. 591-620, especially pp. 598, 1985.
Alexander, “Newcastle Disease in Laboratory Manual for the Isolation and Identification of Avian Pathogens”, Chapter 27, 3rd ed., Purchase, et al., Kendal/Hunt, Iowa, p. 117, 1989.
Prestrelski, et al., “Separation of Freezing-and Drying-induced denaturation of Lyophilized Proteins using Stress-Specific Stabilization”, Archives of Biochemistry and Biophysics, vol. 303, No. 2 pp. 465-473, 1993.
Guo, et al., “Tehalose expression confers desiccation tolerance on human cells”, Nature Biotechnology, vol. 18, pp. 168-171, 2000.
Burke, et al., Formulation, Stability, and Delivery of Live Attenuated Vaccines for Human, Critical Reviews in Therapeutic Drug Carrier Systems, vol. 16, Issue 1, pp. 1-83, 1999.
Wade et al. eds., “Polyoxythylene Sorbitan Fatty Acid Esters”, Handbook of Pharmaceutical Excipients, 2d ed., Amer. Pharm. Assoc., Washington, p. 375 (1994).
Howell, et al., “Effect on Sucrose Phosphate and Sorbitol on Infectivity of Enveloped Viruses During Storage”, Journal of Clinical Microbiology, 18(3):658-662, Sep. 1983.
Chen Tzer-Fen
Jang Jouhn-Wern
Miller Jeffrey A.
Kreisler Lewis J.
Salimi Ali R.
Wellstat Biologics Corporation
LandOfFree
Stable and filterable enveloped virus formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable and filterable enveloped virus formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable and filterable enveloped virus formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2633635